Olivosciences
1 known investors
Find your way into Olivosciences
Sign up to see every warm intro you have to Olivosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Olivosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Olivo Sciences licenses de-identified multimodal patient data (multi-omics, imaging, clinical, and wearable) and provides domain-trained AI models for biopharma companies across the drug development cycle, with a focus on brain and neurological disorders. It supports target discovery, clinical trial design and enrollment, and post-marketing real-world evidence generation.
Investors · 1
Frequently asked questions
- What does Olivosciences do?
- Olivo Sciences licenses de-identified multimodal patient data (multi-omics, imaging, clinical, and wearable) and provides domain-trained AI models for biopharma companies across the drug development cycle, with a focus on brain and neurological disorders. It supports target discovery, clinical trial design and enrollment, and post-marketing real-world evidence generation.
- Who are Olivosciences's investors?
- Olivosciences's investors include DTA Capital Advisors, LLC.